Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
American Journal of Nephrology|March 25, 2021
Mass Screening Is Associated with Low Rates of Acute Kidney Injury among COVID-19 Patients in Hong KongKam Wa Chan, Ivan Fan-Ngai Hung, Owen Tak-Yin Tsang, et al.
BMJ Open|January 13, 2021
Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trialKam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 26, 2023
Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKDFranco Wing Tak Cheng, Vincent Ka Chun Yan, Eric Yuk Fai Wan, et al.
Nephrology (Carlton, Vic.)|November 21, 2017
Relatives in silent kidney disease screening (RISKS) study: A Chinese cohort studyPhilip Kam-Tao Li, Jack Kit-Chung Ng, Yuk Lun Cheng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 29, 2024
Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trialKam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on DialysisIvan Fan-Ngai Hung, Desmond Yat-Hin Yap, Terence Pok-Siu Yip, et al.
Plos Medicine|June 21, 2022
Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective studyCarlos King Ho Wong, Kristy Tsz Kwan Lau, Xi Xiong, et al.
BMC Complementary Medicine and Therapies|July 4, 2020
Patients' and clinicians' expectations on integrative medicine Services for Diabetes: a focus group studyKam Wa Chan, Pak Wing Lee, Crystal Pui Sha Leung, et al.
BMJ Open|August 7, 2016
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trialKam Wa Chan, Tai Pang Ip, Alfred Siu Kei Kwong, et al.
Eclinicalmedicine|May 17, 2023
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKIvan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, et al.
Pageof 6